Position in VRTX
as of Jun 30, 2026
· filed Jul 6, 2026
Position Value
$219,554
-$9,967 QoQ
Shares Held
442
-14.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#235
of 331 holders
Holding Since
Dec 2021
16 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CoreCap Advisors, LLC holds $2,312,000 across 78 Biotechnology names. VRTX ranks #4 (9.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
6,755 | $367,539 | |
| 2 | MRNA |
Moderna, Inc.
|
4,595 | $321,787 | |
| 3 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
3,000 | $244,530 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
442 | $219,554 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
315 | $196,415 | |
| 6 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
280 | $150,346 | |
| 7 | ANIX |
Anixa Biosciences Inc
|
52,020 | $145,656 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
428 | $135,286 |
All Filings in VRTX
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $219,554 | 442 | Shares | Sole | 2026-07-06 | |
| 2026-03-31 | $229,521 | 514 | Shares | Sole | 2026-04-07 | |
| 2025-12-31 | $235,747 | 520 | Shares | Sole | 2026-01-13 | |
| 2025-09-30 | $191,903 | 490 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $641,978 | 1,442 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $388,340 | 801 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $493,710 | 1,226 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $3,649,947 | 7,848 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $325,291 | 694 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $789,202 | 1,888 | Shares | Sole | 2024-08-08 | |
| 2023-12-31 | $607,486 | 1,493 | Shares | Sole | 2024-01-16 | |
| 2023-09-30 | $243,418 | 700 | Shares | Sole | 2024-01-16 | |
| 2022-12-31 | $378,013 | 1,309 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $1,745,347 | 6,028 | Shares | Sole | 2023-02-10 | |
| 2022-06-30 | $1,627,055 | 5,774 | Shares | Sole | 2022-08-11 | |
| 2021-12-31 | $81,691 | 372 | Shares | Sole | 2022-02-10 | |
| No filing history on record for this holder in this stock. | ||||||